bf/NASDAQ:AVXL_icon.jpeg

COM:ANAVEX

Anavex Life Sciences Corp.

  • Stock

Last Close

5.71

31/10 20:00

Market Cap

391.04M

Beta: -

Volume Today

5.84M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
average inventory
-1.32M
-
-1.32M
0%
average payables
1.76M
-
3.76M
113.22%
4.36M
16.19%
4.28M
1.88%
4.07M
4.88%
average receivables
38.42K
-
78.09K
103.26%
44.55K
42.96%
24.96K
43.97%
1.34M
5,274.54%
3.75M
179.25%
6.99M
86.68%
6.16M
11.85%
2.95M
52.13%
book value per share
0.02
-
0.69
3,408.08%
0.18
73.96%
0.59
230.94%
0.46
22.73%
0.41
9.59%
0.47
12.81%
2.16
361.65%
1.85
14.25%
1.78
4.04%
capex per share
-0.00
-
capex to depreciation
-3.93
-
capex to operating cash flow
0.00
-
capex to revenue
cash per share
0.74
-
0.82
11.08%
0.26
68.24%
0.67
157.10%
0.51
23.57%
0.45
11.66%
0.50
10.80%
2.18
333.56%
1.94
11.00%
1.89
2.40%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.80
-
0.01
99.31%
debt to equity
30.69
-
0.01
99.98%
dividend yield
earnings yield
-1.58
-
-0.12
92.67%
-0.12
0.03%
-0.08
31.07%
-0.15
90.29%
-0.17
12.31%
-0.10
41.67%
-0.03
69.52%
-0.06
99.79%
-0.09
50.33%
enterprise value
5.87M
-
89.61M
1,427.72%
118.42M
32.15%
141.64M
19.61%
92.28M
34.85%
132.36M
43.43%
235.54M
77.95%
1.10B
367.38%
644.55M
41.45%
371.58M
42.35%
enterprise value over ebitda
-0.51
-
-7.40
1,363.02%
-7.87
6.37%
-9.10
15.56%
-4.82
47.00%
-4.58
4.97%
-7.58
65.45%
-26.41
248.34%
-12.87
51.27%
-7.82
39.21%
ev to operating cash flow
-2.21
-
-21.20
861.15%
-12.82
39.53%
-15.71
22.52%
-7.33
53.31%
-7.14
2.59%
-11.06
54.88%
-36.23
227.45%
-26.59
26.60%
-13.37
49.71%
ev to sales
free cash flow per share
-0.27
-
-0.23
16.24%
-0.26
15.53%
-0.22
15.97%
-0.28
27.62%
-0.38
34.45%
-0.37
3.44%
-0.44
19.00%
-0.32
27.60%
-0.35
10.50%
free cash flow yield
-0.37
-
-0.04
89.07%
-0.07
79.50%
-0.05
26.32%
-0.11
104.78%
-0.12
9.77%
-0.08
32.94%
-0.02
69.84%
-0.03
25.93%
-0.05
74.10%
graham net net
0.01
-
0.68
6,510.06%
0.17
74.77%
0.58
239.18%
0.43
26.89%
0.36
14.77%
0.44
20.73%
2.12
382.88%
1.84
13.42%
1.76
4.16%
graham number
0.72
-
3.18
343.98%
1.30
59.07%
2.10
61.30%
2.01
4.27%
2.24
11.52%
2.18
2.66%
5.14
135.62%
5.10
0.75%
4.88
4.31%
income quality
0.23
-
0.35
49.24%
0.63
79.54%
0.67
6.88%
0.72
7.61%
0.70
2.26%
0.81
14.96%
0.80
1.05%
0.51
36.97%
0.58
15.78%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
-418.81
-
-98.97
76.37%
-1.31
98.67%
-57.44
-
-49.27
14.22%
interest debt per share
0.60
-
0.01
98.60%
0.32
3,702.97%
0.01
-
0.01
1.87%
inventory turnover
invested capital
30.69
-
0.01
99.98%
market cap
7.22M
-
104.82M
1,352.55%
127.61M
21.74%
169.08M
32.50%
115.21M
31.86%
154.54M
34.14%
264.79M
71.33%
1.25B
373.20%
793.71M
36.65%
522.61M
34.16%
net current asset value
190.38K
-
12.81M
6,627.50%
6.26M
51.16%
24.20M
286.87%
20.44M
15.55%
20.29M
0.73%
27.24M
34.24%
150.82M
453.73%
142.49M
5.52%
141.85M
0.45%
net debt to ebitda
0.12
-
1.26
978.35%
0.61
51.37%
1.76
188.57%
1.20
32.02%
0.77
35.90%
0.94
22.57%
3.65
287.59%
2.98
18.39%
3.18
6.76%
net income per share
-1.16
-
-0.65
43.81%
-0.42
35.66%
-0.33
21.38%
-0.39
18.59%
-0.54
37.56%
-0.45
16.01%
-0.54
20.26%
-0.62
14.87%
-0.60
4.58%
operating cash flow per share
-0.27
-
-0.23
16.15%
-0.26
15.53%
-0.22
15.97%
-0.28
27.62%
-0.38
34.45%
-0.37
3.44%
-0.44
19.00%
-0.32
27.60%
-0.35
10.50%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-1.55
-
-0.78
49.37%
-1.55
98.22%
-0.48
68.83%
-0.72
48.08%
-1.04
44.99%
-0.76
26.71%
-0.23
69.17%
-0.31
33.95%
-0.31
2.09%
revenue per share
roe
-59.02
-
-0.95
98.40%
-2.34
147.14%
-0.55
76.24%
-0.85
53.47%
-1.30
52.16%
-0.96
25.55%
-0.25
73.95%
-0.34
33.96%
-0.33
0.57%
roic
-0.49
-
-0.55
13.95%
-2.36
326.11%
-0.64
72.77%
-0.94
46.09%
-1.42
51.20%
-1.13
20.49%
-0.28
75.23%
-0.38
37.40%
-0.33
12.96%
sales general and administrative to revenue
shareholders equity per share
0.02
-
0.69
3,408.08%
0.18
73.96%
0.59
230.94%
0.46
22.73%
0.41
9.59%
0.47
12.81%
2.16
361.65%
1.85
14.25%
1.78
4.04%
stock based compensation to revenue
tangible asset value
192.63K
-
12.81M
6,549.68%
6.31M
50.75%
24.25M
284.49%
20.49M
15.51%
20.29M
0.98%
27.24M
34.24%
150.82M
453.73%
142.49M
5.52%
141.85M
0.45%
tangible book value per share
0.02
-
0.69
3,408.08%
0.18
73.96%
0.59
230.94%
0.46
22.73%
0.41
9.59%
0.47
12.81%
2.16
361.65%
1.85
14.25%
1.78
4.04%
working capital
5.91M
-
12.81M
116.71%
6.26M
51.16%
24.20M
286.87%
20.44M
15.55%
20.29M
0.73%
27.24M
34.24%
150.82M
453.73%
142.49M
5.52%
141.85M
0.45%

All numbers in (except ratios and percentages)